Xiaofei Gu
Impact in
-
- Cancer-related molecular mechanisms research
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
-
- RNA modifications and cancer 3
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
- S100 Proteins and Annexins 2
- Cancer-related gene regulation 2
- Co-authors
- Luhui Cai (3 shared papers)Qiong Xu (3 shared papers)Di Li (3 shared papers)Yiwen Zhang (2 shared papers)Hongshi Cai (1 shared paper)Heng Li (1 shared paper)Qimeng Li (1 shared paper)Zhen Wang (1 shared paper)
- Journals
- PLoS ONE (2 papers)Journal of Cardiovascular Pharmacology (1 paper)Medicine (1 paper)International Journal of Nanomedicine (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- China
In The Last Decade
Xiaofei Gu
14 papers receiving 375 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 144
- Internal Medicine 17
- Molecular Biology 279
- Immunology 40
- Pulmonary and Respiratory Medicine 60
Countries citing papers authored by Xiaofei Gu
This map shows the geographic impact of Xiaofei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Gu more than expected).
Fields of papers citing papers by Xiaofei Gu
This network shows the impact of papers produced by Xiaofei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Gu. The network helps show where Xiaofei Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofei Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 151 | |
| 2 | 2019 | 120 | |
| 3 | 2016 | 24 | |
| 4 | 2022 | 21 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 13 | |
| 7 | 2022 | 9 | |
| 8 | 2011 | 7 | |
| 9 | 2021 | 3 | |
| 10 | 2019 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2022 | 1 |
About Xiaofei Gu
Xiaofei Gu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Surgery and Small Animals, having authored 14 papers that have together received 375 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), Epigenetics and DNA Methylation (2 papers), RNA Research and Splicing (2 papers), S100 Proteins and Annexins (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Lung Cancer Treatments and Mutations (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (144 citations), Internal Medicine (17 citations), Molecular Biology (279 citations), Immunology (40 citations) and Pulmonary and Respiratory Medicine (60 citations). Xiaofei Gu has collaborated with scholars based in China. Frequent co-authors include Luhui Cai, Qiong Xu, Di Li, Yiwen Zhang, Hongshi Cai, Heng Li, Qimeng Li, Zhen Wang, Liyong Chen and Zhihui Feng. Their work appears in journals such as PLoS ONE, Journal of Cardiovascular Pharmacology, Medicine, International Journal of Nanomedicine and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.